Image For Activity Cover
SSO Virtual Tumor Board: Peritoneal Surface Malignancies
Activity Overview

In this tumor board, the participants will be able to:

  • Learn the results of the landmark PRODIGE 7 randomized trial. 
  • Review current status of cytoreductive surgery for peritoneal metastases from colorectal cancer.
  • Review current status of Hipec for peritoneal metastasis from colorectal cancer.

Moderating this session will be SSO's Peritonal Surface Malignancy Disease Site Work Group Chair, Kiran K. Turaga, MD, MPH, University of Chicago and Vice Chair, Edward A. Levine, MD, Wake Forest University.

Panelists:
Diane Goere, MD, PHD, Hôpitaux de Paris/ Hôpital Saint-Louis
Quenet Francois, MD, Institut du Cancer de Montpellier Val d'Aurelle

Summary
Availability: No future session
Cost: FREE
Credit Offered:
No Credit Offered
Powered By